Yang JianYu

Dr. Yang JianYu


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Cancer Letters
Verified
Journal Article
Closed access
JZJun-Feng Zhang
Jun-Feng Zhang
LTLing-Ye Tao
Ling-Ye Tao
MYMin-Wei Yang
Min-Wei Yang
DXDa-Peng Xu
Da-Peng Xu
SJShu-Heng Jiang
Shu-Heng Jiang
YSYongwei Sun
Yongwei Sun

22 August 2015 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
YHYanmiao Huo
Yanmiao Huo
MYMinwei Yang
Minwei Yang
WLWei Liu
Wei Liu
YJYang JianYu
Yang JianYu
XFXueliang Fu
Xueliang Fu
YSYongwei Sun
Yongwei Sun
Discoidin domain receptors 1 (DDR1), a subtype of DDRs, has been reported as a critical modulator of cellular morphogenesis, differentiation, migration and invasion. In this study, we investigated the expression of DDR1 and its clinical association in Chinese patients with pancreatic ductal adenocarcinoma (PDAC). Across a cohort of 30 patients, we examined DDR1 expression in paired PDAC and corresponding adjacent non-tumor tissues by real-time quantitative PCR (RT-qPCR), or western blotting. DDR1 expression is significantly higher in PDAC, as compared to normal adjacent tissue, confirming results from the Oncomine databases. We validated DDR1 expression by immunohistochemistry across a non-overlapping cohort of 205 PDAC specimens. Kaplan-Meier survival curves indicate that increased expression of DDR1 is associated with a poor prognosis in PDAC patients (P = 0.013). Multivariate Cox regression analysis identified DDR1 expression, age, N classification and liver metastasis as independent prognostic factors in PDAC. This study demonstrated that DDR1 can well serve as a novel prognostic biomarker in PDAC.

20 April 2023 in Apoptosis
Verified
Journal Article
Closed access
PDF file
HYHong-Fei Yao
Hong-Fei Yao
DXDa-Peng Xu
Da-Peng Xu
JZJia-Hao Zheng
Jia-Hao Zheng
YXYu Xu
Yu Xu
QJQin-Yuan Jia
Qin-Yuan Jia
JZJun-Feng Zhang
Jun-Feng Zhang


6 September 2024 in Cancer Letters
Verified
Journal Article
Closed access
RHRong Hua
Rong Hua
HYHong-Fei Yao
Hong-Fei Yao
ZSZi-Yu Song
Zi-Yu Song
FYFeng Yu
Feng Yu
ZCZhao-Yu Che
Zhao-Yu Che
JZJun-Feng Zhang
Jun-Feng Zhang

28 October 2022 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
JZJia-Hao Zheng
Jia-Hao Zheng
HYHong-Fei Yao
Hong-Fei Yao
ZDZong-Hao Duan
Zong-Hao Duan
PJPeixuan Ji
Peixuan Ji
JYJian Yang
Jian Yang
LCLi Chen
Li Chen
Pancreatic adenocarcinoma (PAAD), one of the most malignant tumors, not only has abundant mesenchymal components, but is also characterized by an extremely high metastatic risk. The purpose of this study was to construct a model of stroma- and metastasis-associated prognostic signature, aiming to benefit the existing clinical staging system and predict the prognosis of patients. First, stroma-associated genes were screened from the TCGA database with the ESTIMATE algorithm. Subsequently, transcriptomic data from clinical tissues in the RenJi cohort were screened for metastasis-associated genes. Integrating the two sets of genes, we constructed a risk prognostic signature by Cox and LASSO regression analysis. We then obtained a risk score by a quantitative formula and divided all samples into high- and low-risk groups based on the scores. The results demonstrated that patients with high-risk scores have a worse prognosis than those with low-risk scores, both in the TCGA database and in the RenJi cohort. In addition, tumor mutation burden, chemotherapeutic drug sensitivity and immune infiltration analysis also exhibited significant differences between the two groups. In exploring the potential mechanisms of how stromal components affect tumor metastasis, we simulated different matrix stiffness in vitro to explore its effect on EMT key genes in PAAD cells. We found that cancer cells stimulated by high matrix stiffness may trigger EMT and promote PAAD metastasis.